Mati Gill is CEO of AION Labs, a venture studio with a first-of-its-kind company creation model for new start-ups utilizing AI for drug discovery and development. Supported by the Israeli Government, AION Labs was formed from the unique alliance of Pfizer, Amazon Web Services, AstraZeneca, Teva Pharmaceuticals, Merck, the Israel Biotech Fund, Amiti Ventures and BioMed X. Prior to founding AION Labs, Mati was a senior executive at Teva Pharmaceuticals and served as Chief of Staff for Israel’s Minister of Public Security. He is an IDF veteran (Maj. res.) serves on the boards of the Israel Advanced Technology Industries Association (IATI) and the Israel America Chamber of Commerce (AmCham).